Anti-Inflammatory Therapy as a Promising Target in Neuropsychiatric Disorders.

No abstract is available for this paper.

• Publication year

  2023

• Venue

  Advances in Experimental Medicine and Biology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/978-981-19-7376-5_20PMID 36949322
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prostanoids and Resolution of Inflammation – Beyond the Lipid-Mediator Class Switch

  2021cited by this paper
• Neuroinflammation and the Kynurenine Pathway in CNS Disease: Molecular Mechanisms and Therapeutic Implications

  2021cited by this paper
• Cytokine Imbalance in Schizophrenia. From Research to Clinic: Potential Implications for Treatment

  2021cited by this paper
• Augmentation therapy with minocycline in treatment-resistant depression patients with low-grade peripheral inflammation: results from a double-blind randomised clinical trial

  2021cited by this paper
• Cerebrospinal Fluid Inflammatory Cytokine Levels in Patients With Major Psychiatric Disorders: A Multiplex Immunoassay Study

  2021cited by this paper
• Revisiting steroidogenesis and its role in immune regulation with the advanced tools and technologies

  2021cited by this paper
• Anti-TNF-α Compounds as a Treatment for Depression

  2021cited by this paper
• Adjunctive Aspirin vs Placebo in Patients With Schizophrenia: Results of Two Randomized Controlled Trials.

  2021cited by this paper
• Glial Cells as Regulators of Neuroimmune Interactions in the Central Nervous System

  2020cited by this paper
• Increased inflammatory biomarkers and changes in biological rhythms in bipolar disorder: A case-control study.

  2020cited by this paper
• Neuroinflammatory alterations in trait anxiety: modulatory effects of minocycline

  2020cited by this paper
• Modulation of the inflammatory response benefits treatment-resistant bipolar depression: A randomized clinical trial.

  2020cited by this paper
• The Inflamed Brain in Schizophrenia: The Convergence of Genetic and Environmental Risk Factors That Lead to Uncontrolled Neuroinflammation

  2020cited by this paper
• The Role of Brain Cyclooxygenase-2 (Cox-2) Beyond Neuroinflammation: Neuronal Homeostasis in Memory and Anxiety

  2020cited by this paper
• Anti-inflammatory Strategies for Schizophrenia: A Review of Evidence for Therapeutic Applications and Drug Repurposing

  2020cited by this paper
• Posttraumatic stress disorder and risk of selected autoimmune diseases among US military personnel

  2020cited by this paper
• A single administration of the antibiotic, minocycline, reduces fear processing and improves implicit learning in healthy volunteers: analysis of the serum metabolome

  2020cited by this paper
• Efficacy and safety of anti-inflammatory agents in treatment of psychotic disorders - a comprehensive systematic review and meta-analysis.

  2020cited by this paper
• Evaluation of the arachidonic acid pathway in bipolar disorder: a systematic review

  2020cited by this paper
• Aberrant inflammatory profile in acute but not recovered anorexia nervosa.

  2020cited by this paper
• Aspirin and other non-steroidal anti-inflammatory drugs and depression, anxiety, and stress-related disorders following a cancer diagnosis: a nationwide register-based cohort study

  2020cited by this paper
• Dysfunction of inflammatory pathways in adolescent female patients with anorexia nervosa.

  2020cited by this paper
• Minocycline in neurodegenerative and psychiatric diseases: An update

  2020cited by this paper
• Cyclooxygenase Inhibition Safety and Efficacy in Inflammation-Based Psychiatric Disorders

  2020cited by this paper
• Peripheral Markers of Depression

  2020cited by this paper
• Overlapping evidence of innate immune dysfunction in psychotic and affective disorders.

  2020cited by this paper
• Inflammation in Bipolar Disorder (BD): Identification of New Therapeutic Targets.

  2020cited by this paper
• Serum Metabolic Profiles of the Tryptophan-Kynurenine Pathway in the high risk subjects of major depressive disorder

  2020cited by this paper
• The Legacy of Sickness Behaviors

  2020cited by this paper
• An update on the efficacy of anti-inflammatory agents for patients with schizophrenia: a meta-analysis

  2019cited by this paper
• Nonsteroidal anti-inflammatory drugs (NSAIDs) reduce suicidal ideation and depression.

  2019cited by this paper
• Statins and Inflammation: New Therapeutic Opportunities in Psychiatry

  2019cited by this paper
• Efficacy of anti‐inflammatory treatment on major depressive disorder or depressive symptoms: meta‐analysis of clinical trials

  2019cited by this paper
• Constructing the Immune Signature of Schizophrenia for Clinical Use and Research; An Integrative Review Translating Descriptives Into Diagnostics

  2019cited by this paper
• Immunoneuropsychiatry — novel perspectives on brain disorders

  2019cited by this paper
• Inflammation and post‐traumatic stress disorder

  2019cited by this paper
• Recycling N-acetylcysteine: A review of evidence for adjunctive therapy in schizophrenia

  2019cited by this paper
• Glucocorticoid-induced enhancement of extinction—from animal models to clinical trials

  2019cited by this paper
• A potential role for adjunctive omega-3 polyunsaturated fatty acids for depression and anxiety symptoms in recent onset psychosis: Results from a 16 week randomized placebo-controlled trial for participants concurrently treated with risperidone.

  2019cited by this paper
• Inflammation and depression but where does the inflammation come from?

  2019cited by this paper
• COX-2 Inhibitors, Aspirin, and Other Potential Anti-Inflammatory Treatments for Psychiatric Disorders

  2019cited by this paper
• Peripheral Biomarkers of Inflammation in Depression: Evidence from Animal Models and Clinical Studies.

  2019cited by this paper
• Psychosis as an adverse effect of monoclonal antibody immunotherapy.

  2019cited by this paper
• Low-Grade Inflammation as a Predictor of Antidepressant and Anti-Inflammatory Therapy Response in MDD Patients: A Systematic Review of the Literature in Combination With an Analysis of Experimental Data Collected in the EU-MOODINFLAME Consortium

  2019cited by this paper
• Interplay between inflammation and neural plasticity: both immune activation and suppression impair LTP and BDNF expression.

  2019cited by this paper
• Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders

  2019cited by this paper
• A Brief History of Immunological Research into Psychosis and Pathways for Immune Influence of the Brain.

  2019cited by this paper
• Neuroendocrine Regulation of Brain Cytokines After Psychological Stress

  2019cited by this paper
• Cytokine concentrations are related to level of mental distress in inpatients not using anti-inflammatory drugs

  2019cited by this paper
• Chronic Glucocorticoid Exposure Induces Depression-Like Phenotype in Rhesus Macaque (Macaca Mulatta)

  2019cited by this paper
• Cytokine Alterations in Schizophrenia: An Updated Review

  2019cited by this paper
• Glucocorticoids and Hippocampal Structure and Function in PTSD.

  2018cited by this paper
• N-Acetylcysteine for the Treatment of Psychiatric Disorders: A Review of Current Evidence

  2018cited by this paper
• Adjunctive therapy with statins in schizophrenia patients: A meta-analysis and implications.

  2018cited by this paper
• Immune-based strategies for mood disorders: facts and challenges

  2018cited by this paper
• Inflammation–Nature's Way to Efficiently Respond to All Types of Challenges: Implications for Understanding and Managing “the Epidemic” of Chronic Diseases

  2018cited by this paper
• Population scale retrospective analysis reveals distinctive antidepressant and anxiolytic effects of diclofenac, ketoprofen and naproxen in patients with pain

  2018cited by this paper
• CANS: Childhood acute neuropsychiatric syndromes.

  2018cited by this paper
• Neuroimmune Interactions: From the Brain to the Immune System and Vice Versa.

  2018cited by this paper
• IDO and TDO as a potential therapeutic target in different types of depression

  2018cited by this paper
• The anti-inflammatory mechanism of antidepressants - SSRIs, SNRIs.

  2018cited by this paper
• Meta-analysis of Cerebrospinal Fluid Cytokine and Tryptophan Catabolite Alterations in Psychiatric Patients: Comparisons Between Schizophrenia, Bipolar Disorder, and Depression

  2018cited by this paper
• Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis

  2018cited by this paper
• Inflammation in Schizophrenia: Pathogenetic Aspects and Therapeutic Considerations

  2018cited by this paper
• Anti-inflammatory treatment of depression: study protocol for a randomised controlled trial of vortioxetine augmented with celecoxib or placebo

  2018cited by this paper
• The Gut-Brain Axis: Influence of Microbiota on Mood and Mental Health.

  2018cited by this paper
• Damage-Associated Molecular Patterns in Inflammatory Diseases

  2018cited by this paper
• Immune system and obsessive-compulsive disorder.

  2018cited by this paper
• Association of Streptococcal Throat Infection With Mental Disorders: Testing Key Aspects of the PANDAS Hypothesis in a Nationwide Study

  2017cited by this paper
• The Immune System, Cytokines, and Biomarkers in Autism Spectrum Disorder

  2017cited by this paper
• Adjunctive celecoxib for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials.

  2017cited by this paper
• New Targets for Schizophrenia Treatment beyond the Dopamine Hypothesis

  2017cited by this paper
• The Role of the Immune System in Autism Spectrum Disorder

  2017cited by this paper
• Bipolar Disorder and Immune Dysfunction: Epidemiological Findings, Proposed Pathophysiology and Clinical Implications

  2017cited by this paper
• Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy

  2017cited by this paper
• Affective immunology: where emotions and the immune response converge

  2017cited by this paper
• Brain microglia in psychiatric disorders.

  2017cited by this paper
• Immune disorders in anorexia

  2017cited by this paper
• Inflammation and depression: a causal or coincidental link to the pathophysiology?

  2017cited by this paper
• Inflammation: opportunities for treatment stratification among individuals diagnosed with mood disorders

  2017cited by this paper
• Inflammatory dysregulation of monocytes in pediatric patients with obsessive-compulsive disorder

  2017cited by this paper
• Posttraumatic Stress Disorder: An Immunological Disorder?

  2017cited by this paper
• Immune regulation by glucocorticoids

  2017cited by this paper
• Are Non-steroidal Anti-Inflammatory Drugs Clinically Suitable for the Treatment of Symptoms in Depression-Associated Inflammation?

  2016cited by this paper
• Corrigendum to "Efficacy of adjunctive celecoxib treatment for patients with major depressive disorder: A meta-analysis" [Prog. Neuro-Psychopharmacol. Biol. Psychiatry 48 (3 January 2014) 79-85].

  2016cited by this paper
• Celecoxib Adjunctive Treatment to Antipsychotics in Schizophrenia: A Review of Randomized Clinical Add-On Trials

  2016cited by this paper
• Electric stimulation of the vagus nerve reduced mouse neuroinflammation induced by lipopolysaccharide

  2016cited by this paper
• Critical appraisal of omega-3 fatty acids in attention-deficit/hyperactivity disorder treatment

  2016cited by this paper
• Minocycline and celecoxib as adjunctive treatments for bipolar depression: a study protocol for a multicenter factorial design randomized controlled trial

  2016cited by this paper
• Effect of Probiotics on Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

  2016cited by this paper
• The Case for Adjunctive Monoclonal Antibody Immunotherapy in Schizophrenia.

  2016cited by this paper
• Maternal autoimmune diseases and the risk of autism spectrum disorders in offspring: A systematic review and meta-analysis.

  2016cited by this paper
• Are Anti-inflammatory Therapies Viable Treatments for Psychiatric Disorders?: Where the Rubber Meets the Road.

  2015cited by this paper
• The role of inflammation in depression: from evolutionary imperative to modern treatment target

  2015cited by this paper
• Characterization of the Pediatric Acute-Onset Neuropsychiatric Syndrome Phenotype

  2015cited by this paper
• A critical review of the efficacy of non-steroidal anti-inflammatory drugs in depression.

  2015cited by this paper
• Celecoxib as an Adjuvant to Fluvoxamine in Moderate to Severe Obsessive-compulsive Disorder: A Double-blind, Placebo-controlled, Randomized Trial

  2015cited by this paper
• Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review.

  2015cited by this paper
• Neuropsychiatric disorders in Cushing's syndrome

  2015cited by this paper
• Mood, Personality, and Behavior Changes During Treatment with Statins: A Case Series

  2015cited by this paper

• Preclinical rodent studies support minocycline as an adjunctive anxiolytic.

  2026cites this paper
• A Comprehensive Analysis of Inflammation Regulatory Biomarkers among three Neuropsychiatric Disorders using Transcriptomic Approach

  2026cites this paper
• Neutrophil-to-lymphocyte ratio; platelet-to-lymphocyte ratio; systemic immune-inflammatory Index: inflammatory indicators of cognitive impairment in schizophrenia patients

  2025cites this paper
• Steroids for the Treatment of Misophonia and Misokinesia

  2024cites this paper
• Neuroinflammation in the prefrontal-amygdala-hippocampus network is associated with maladaptive avoidance behaviour.

  2024cites this paper